Literature DB >> 19321494

Is lowering phosphate exposure the key to preventing arterial stiffening with age?

C J Ferro1, C D Chue, R P Steeds, J N Townend.   

Abstract

Cardiovascular disease remains the leading cause of death world wide. Although atheroma is clearly important, the role of arteriosclerotic vascular disease is often overlooked. Arteriosclerosis causes increased arterial stiffness, with consequent systolic hypertension and left ventricular hypertrophy. Serum phosphate is increasingly being recognised as a cardiovascular risk factor and has been implicated in the development of arteriosclerosis and arterial calcification. Its determinants are unclear, but both diet and minor reductions in renal function may be important. Diets in affluent populations are high in phosphate because of increased consumption of animal protein and the use of phosphate-containing preservatives. This viewpoint suggests that the consumption of a phosphate-rich diet, exacerbated by the high prevalence of chronic kidney disease found in ageing populations, accelerates the development of arteriosclerosis. It is hypothesised that reducing phosphate intake will attenuate the progression of arterial stiffness with major beneficial effects upon cardiovascular mortality and morbidity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321494     DOI: 10.1136/hrt.2008.162594

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  6 in total

1.  Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Paul Muntner; Michal L Melamed; Caroline S Fox
Journal:  Nephrol Dial Transplant       Date:  2011-02-03       Impact factor: 5.992

2.  Cardiovascular effects of sevelamer in stage 3 CKD.

Authors:  Colin D Chue; Jonathan N Townend; William E Moody; Daniel Zehnder; Nadezhda A Wall; Lorraine Harper; Nicola C Edwards; Richard P Steeds; Charles J Ferro
Journal:  J Am Soc Nephrol       Date:  2013-04-18       Impact factor: 10.121

3.  An integrated understanding of the physiological response to elevated extracellular phosphate.

Authors:  Corinne E Camalier; Ming Yi; Li-Rong Yu; Brian L Hood; Kelly A Conrads; Young Jae Lee; Yiming Lin; Laura M Garneys; Gary F Bouloux; Matthew R Young; Timothy D Veenstra; Robert M Stephens; Nancy H Colburn; Thomas P Conrads; George R Beck
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

4.  Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients.

Authors:  Lee-Moay Lim; Hung-Tien Kuo; Mei-Chuan Kuo; Yi-Wen Chiu; Jia-Jung Lee; Shang-Jyh Hwang; Jer-Chia Tsai; Chi-Chih Hung; Hung-Chun Chen
Journal:  BMC Nephrol       Date:  2014-11-21       Impact factor: 2.388

Review 5.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

6.  Modulation of stroke risk in chronic kidney disease.

Authors:  Julia Arnold; Don Sims; Charles J Ferro
Journal:  Clin Kidney J       Date:  2015-12-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.